Related Experiment Video
Updated: Jan 13, 2026

12:27
A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
3.9K
Strategic advances for cryo-EM structural studies of small (<100 kDa) GPCRs
Swapnil Kumar Singh1, Mahek Agrawal1, Amrutansu Pattanayak1
1Department of Biological Sciences, Indian Institute of Science Education and Research Bhopal, Bhopal, Madhya Pradesh, India.
Communications Biology
|January 8, 2026
Summary
Visualizing small G protein-coupled receptors (GPCRs) in inactive states via cryo-electron microscopy (cryo-EM) is challenging. This review covers methods to overcome these hurdles for drug discovery.
Area of Science:
- Structural biology
- Biochemistry
- Pharmacology
Background:
- Membrane proteins, including G protein-coupled receptors (GPCRs), are crucial in cell signaling and represent a major drug target class.
- GPCRs comprise the largest membrane protein family, with approximately 35% of FDA-approved drugs targeting them.
- Cryo-electron microscopy (cryo-EM) has advanced GPCR structural studies, yet resolving small, flexible apo and inactive states remains difficult.
Purpose of the Study:
- To review challenges in visualizing apo and inactive GPCR states using cryo-electron microscopy (cryo-EM).
- To summarize fusion and target-binding strategies for determining GPCR structures.
- To discuss practical aspects of fiducial design and emerging AI approaches in GPCR structural biology.
Main Methods:
- Cryo-electron microscopy (cryo-EM) for structural determination.
- Fusion protein strategies to enhance stability and visualization.
- Target-binding approaches to stabilize specific GPCR conformations.
- Fiducial marker design for improved particle alignment.
- Artificial intelligence (AI) driven methods for image processing and structure prediction.
Main Results:
- Identification of key obstacles in cryo-EM for small, flexible apo/inactive GPCRs.
- Successful application of fusion and target-binding strategies to resolve challenging GPCR structures.
- Guidance on fiducial design for enhanced cryo-EM data quality.
- Highlighting the potential of AI to advance GPCR structural studies.
Conclusions:
- Overcoming cryo-EM limitations is crucial for understanding GPCRs in therapeutically relevant inactive states.
- Fusion and target-binding strategies offer viable solutions for structural determination of challenging GPCR complexes.
- Advancements in AI are poised to further revolutionize GPCR structural biology and drug discovery efforts.

